Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted. The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov. Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

NLM Logo

Radioimmunotherapy MeSH Descriptor Data 2025


MeSH Heading
Radioimmunotherapy
Tree Number(s)
E02.095.465.425.750
E02.186.750
E02.815.520
Unique ID
D016499
RDF Unique Identifier
http://id.nlm.nih.gov/mesh/D016499
Annotation
coordinate with disease /‌radiother
Scope Note
Radiotherapy where cytotoxic radionuclides are linked to antibodies in order to deliver toxins directly to tumor targets. Therapy with targeted radiation rather than antibody-targeted toxins (IMMUNOTOXINS) has the advantage that adjacent tumor cells, which lack the appropriate antigenic determinants, can be destroyed by radiation cross-fire. Radioimmunotherapy is sometimes called targeted radiotherapy, but this latter term can also refer to radionuclides linked to non-immune molecules (see RADIOTHERAPY).
Entry Version
RADIOIMMUNOTHER
Entry Term(s)
Immunoradiotherapy
NLM Classification #
QZ 270
Previous Indexing
Antibodies, Monoclonal/therapeutic use (1984-1991)
Immunotherapy (1984-1991)
specific radioisotope/therapeutic use (1981-1991)
Public MeSH Note
92
History Note
92
Date Established
1992/01/01
Date of Entry
1991/05/02
Revision Date
2009/07/06
Radioimmunotherapy Preferred
page delivered in 0.158s